IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Janssen Research & Development, LLC
National Cancer Institute (NCI)
University of Pittsburgh
Fate Therapeutics
Memorial Sloan Kettering Cancer Center
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
AstraZeneca
University of Chicago
Neonc Technologies, Inc.
University of Chicago
Brown University
Rakuten Medical, Inc.
Nurix Therapeutics, Inc.
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute
Iovance Biotherapeutics, Inc.
Akeso
Fudan University
Lyvgen Biopharma Holdings Limited
Rutgers, The State University of New Jersey